A Deep Dive into a Growing Market & Life-Saving TechnologyThe aorta, the body’s largest artery, is a vital component of the ...

In speaking about Endologix’s portfolio and clinical pipeline ... official start of the U.S. release of the ALTO Abdominal Stent Graft System. The commercial release of ALTO will be supported ...

Notably, the Ovation Alto Abdominal Stent Graft System is the latest addition to Endologix’s existing Ovation Abdominal Stent Graft platform. AAA is one of the most serious cardiovascular ...

“Endologix is committed to replacing Ovation iX with the recently FDA-approved ALTO graft by the end of October 2020. ALTO is technically easier to implant and has been designed to improve acute ...

Although the stent-graft's safety seemed improved with ... "I do believe that there are patient subsets where the Endologix graft can play an important and vital role," surgeon Keith B.

“Endologix is deeply committed to patient ... It mainly concentrates on endovascular stent grafts to treat abdominal aortic aneurysms – a condition resulting from the weakening of the aorta ...

--(BUSINESS WIRE)-- Endologix® Inc. (Nasdaq ... for the Alto™ Abdominal Stent Graft System (Alto). The Company received approval based on its regulatory submission that includes the ELEVATE ...

IRVINE, Calif., Aug. 16 Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today that it has entered into a development agreement and ...

The good news is that sales of Endologix's Ovation abdominal stent graft are growing in the U.S. and AFX sales are still growing in Japan. Unfortunately, it's just not enough to make up for ...

Endologix Inc., of Irvine, Calif., has won approval from the U.S. FDA for its Alto abdominal stent graft system, the company’s next-generation Ovation system for polymer endovascular aneurysm repair ...

Irvine-based stent graft maker Endologix Inc. filed for Chapter 11 bankruptcy on July 5, noting business interruptions due to COVID-19 as partially responsible for the move. Shares for the company ...